Shervin (Seyedtaghi) Takyar MD, PhD

Assistant Professor of Medicine (Pulmonary) and of Molecular Biophysics and Biochemistry

Departments & Organizations

Cancer Center, Yale: Developmental TherapeuticsMolecular Biophysics and BiochemistryInternal Medicine: Pulmonary, Critical Care & Sleep Medicine; Takyar Lab

Research Interests

Non-coding RNAs; Endothelial Responses; Th2 Immunity; Lung Injury; Tumor Microenvironment; Macrophage Activation more...


  • M.D., Iran University of Medical Sciences, 1995
  • Ph.D., University of Queensland, 2002

Selected Publications

  • Takyar S, Vasavada H, Zhang JG, Ahangari F, Lee CG, Niu N, Liu Q, Cohn L, Elias JA. 'VEGF Controls Lung Th2 Inflammation Via the Mir-1-Mpl (Myeloproliferative Leukemia Virus Oncogene)-P-Selectin Axis', Journal of Eexperimental Medicine, 210 (2013), 1993-2010.
  • Ma B, Dela Cruz CS, Hartl D, Kang MJ, Takyar S, Homer RJ, Lee CG, Elias JA. RIG-like helicase innate immunity inhibits vascular endothelial growth factor tissue responses via a type I IFN-dependent mechanism. Am J Respir Crit Care Med. 2011 May 15;183(10):1322-35
  • Takyar S, Hickerson RP, Noller HF. mRNA helicase activity of the ribosome, Cell, 2005, 120:49-58?.



Latest News


Edit Profile